MedTech Market Update, Q1 2026

• The global medical devices market continues to benefit from durable secular tailwinds, including aging demographics, chronic disease prevalence, procedure growth, and technology-enabled care delivery.
• Q1 activity was defined less by volume acceleration alone and more by strategic prioritization, with buyers emphasizing high-conviction platforms in cardiovascular, neurology, patient monitoring, and procedure-adjacent categories.
• Boston Scientific's $12.4B agreement to acquire Penumbra highlights continued strategic appetite for differentiated, scaled assets in large clinical markets where acquirers can leverage existing commercial infrastructure.
• AI is increasingly shifting from an innovation narrative to an operational and clinical productivity lever, particularly across R&D, workflow automation, real-world evidence, diagnostics, and hospital efficiency.
• Care migration remains a key structural theme, with growth in home-based, ambulatory, and connected-care models reshaping product design, reimbursement strategy, distribution channels, and M&A priorities.

Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M -$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.

Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at [email protected].